Lars Hangartner, PhD

Associate Professor of IMS
Department of Immunology and Microbiology
California Campus



Ph.D., Eidgenössische Technische Hochschule, 2002
Diploma (Molecular Biology), University of Zurich, 1997

Professional Experience

2015-2017 Associate Professor, Immunology and Microbial Science (IMS), Scripps Research
2009-2015 Professor SNSF, Institute of Medical Virology, University of Zurich
2008-2009 Staff Scientist, University of Zurich
2005-2008 Senior Research Associate, Scripps Research
2002-2005 Postdoctoral Fellow, University Hospital Zurich

Selected References

All Publications

Nogal, B., Bianchi, M., Cottrell, C. A., Kirchdoerfer, R. N., Sewall, L. M., Turner, H. L., Zhao, F., Sok, D., Burton, D. R., Hangartner, L. & Ward, A. B. Mapping polyclonal antibody responses in non-human primates vaccinated with HIV env trimer subunit vaccines. (2020). Cell Reports, 30(11), 3755-3765. PMCID: PMC7153566.

Hangartner, L. Public endowment of B cells. (2019). Immunity, 51(4), 601-603.

Voss, J. E., Gonzalez-Martin, A., Andrabi, R., Fuller, R. P., Murrell, B., McCoy, L. E., Porter, K., Huang, D., Li, W., Sok, D., Le, K., Briney, B., et al. Reprogramming the antigen specificity of B cells using genome-editing technologies. (2019). Elife, 8. PMCID: PMC6355199.

Pauthner, M. G., Nkolola, J. P., Havenar-Daughton, C., Murrell, B., Reiss, S. M., Bastidas, R., Prevost, J., Nedellec, R., von Bredow, B., Abbink, P., Cottrell, C. A., Kulp, D. W., et al. Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers. (2019). Immunity, 50(1), 241-252. PMCID: PMC6335502.

Bianchi, M., Turner, H. L., Nogal, B., Cottrell, C. A., Oyen, D., Pauthner, M., Bastidas, R., Nedellec, R., McCoy, L. E., Wilson, I. A., Burton, D. R., Ward, A. B., et al. Electron-microscopy-based epitope mapping defines specificities of polyclonal antibodies elicited during HIV-1 BG505 envelope trimer immunization. (2018). Immunity, 49(2), 288-300. PMCID: PMC6104742.

Maurer, M. A., Meyer, L., Bianchi, M., Turner, H. L., Le, N. P. L., Steck, M., Wyrzucki, A., Orlowski, V., Ward, A. B., Crispin, M. & Hangartner, L. Glycosylation of human IgA directly inhibits influenza A and other sialic-acid-binding viruses. (2018). Cell Reports, 23(1), 90-99.

Burton, D. R. & Hangartner, L. Broadly neutralizing antibodies to HIV and their role in vaccine design. (2016). Annual Review of Immunology, 34, 635.

Wyrzucki, A., Bianchi, M., Kohler, I., Steck, M. & Hangartner, L. Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies. (2015). Journal of Virology, 89(6), 3136-3144. PMCID: PMC4337524.

Kohler, I., Kouyos, R., Bianchi, M., Grube, C., Wyrzucki, A., Gunthard, H. F. & Hangartner, L. The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals. (2015). AIDS, 29(14), 1803-1810.

Wyrzucki, A., Dreyfus, C., Kohler, I., Steck, M., Wilson, I. A. & Hangartner, L. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. (2014). Journal of Virology, 88(12), 7083-7092. PMCID: PMC4054347.